Ten-year advances in immunopathology of glomerulonephritis: Translated into patients' care or lost in translation?

Seminars in Immunopathology

Volumn 36, Issue 4, 2014, Pages 377-379

  Ronco, Pierre ^a   Floege, Jürgen ^b  

^a HÔPITAL TENON   (France)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT FACTOR H; FC RECEPTOR; MEGALIN; PHOSPHOLIPASE A2 RECEPTOR;

ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY COMPLEX; COMPLEMENT ACTIVATION; COMPLEMENT ALTERNATIVE PATHWAY; COMPLEMENT FACTOR H GENE; DISEASE CLASSIFICATION; EDITORIAL; ENVIRONMENTAL FACTOR; GENE MUTATION; GENETIC VARIABILITY; GLOMERULONEPHRITIS; HEMOLYTIC UREMIC SYNDROME; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOPATHOLOGY; MEMBRANOUS GLOMERULONEPHRITIS; NONHUMAN; PATIENT CARE; PRIORITY JOURNAL; TRANSLATIONAL RESEARCH; TREATMENT PLANNING; IMMUNOLOGY; PATHOLOGY; PUBLICATION;

GLOMERULONEPHRITIS; HUMANS; PERIODICALS AS TOPIC;

EID: 84905920994     PISSN: 18632297     EISSN: 18632300     Source Type: Journal    
DOI: 10.1007/s00281-014-0437-5     Document Type: Editorial

References (23)

1. Beck LH Jr, Bonegio RG, Lambeau G et al (2009) M-type phospholipase A2 receptor as target antigen in idiopathic MN. N Engl J Med 361:11-21
2. Debiec H, Ronco P (2014) Immunopathogenesis of membranous nephropathy: an update. Semin Immunopathol. doi:10.1007/s00281-014-0423-y (this issue)
3. Van Damme BJ, Fleuren GJ, Bakker WW et al (1978) Experimental glomerulonephritis in the rat induced by antibodies directed against tubular antigens. V. Fixed glomerular antigens in the pathogenesis of heterologous immune complex glomerulonephritis. Lab Invest 38:502-510 (Pubitemid 8338244)
4. Couser WG, Steinmuller DR, Stilmant MM et al (1978) Experimental glomerulonephritis in the isolated perfused rat kidney. J Clin Invest 62:1275-1287 (Pubitemid 9075757)
5. Kerjaschki D, Farquhar M (1982) The pathogenic antigen of Heymann nephritis is a membrane glycoprotein of the renal proximal tubule brush border. Proc Natl Acad Sci 79:5557-5561 (Pubitemid 13197683)
6. Debiec H, Guigonis V, Mougenot B et al (2002) Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies. N Engl J Med 346:2053-2060 (Pubitemid 34680597)
7. Mele C, Remuzzi G, Noris M (2014) Hemolytic uremic syndrome. Semin Immunopathol. doi:10.1007/s00281-014-0416-x (this issue)
8. Warwicker P, Goodship TH, Donne RL et al (1998) Genetic studies into inherited and sporadic hemolytic uremic syndrome. Kidney Int 53:836-844 (Pubitemid 28155655)
9. Dragon-Durey MA, Loirat C, Cloarec S et al (2005) Anti-factor H autoantibodies associated with atypical hemolytic uremic syndrome. J Am Soc Nephrol 16:555-563 (Pubitemid 41725154)
10. Legendre CM, Licht C, Muus P et al (2013) Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome. N Engl J Med 368:2169-2181
11. Sahali D, Sendeyo K, Mangier M et al (2013) Immunopathogenesis of idiopathic nephrotic syndromewith relapse. Semin Immunopathol. doi:10.1007/s00281-013-0415-3 (this issue)
12. Floege J, Moura IC, Daha MR (2014) New insights into the pathogenesis of IgA nephropathy. Semin Immunopathol. doi:10.1007/s00281-013-0411-7 (this issue)
13. McKinney EF, Willcocks LC, Broecker V, Smith KGC (2014) The immunopathology of ANCA-associated vasculitis. Semin Immunopathol. doi:10.1007/s00281-014-0436-6 (this issue)
14. Anders H-J, Fogo AB (2013) Immunopathology of lupus nephritis. Semin Immunopathol. doi:10.1007/s00281-013-0413-5 (this issue)
15. Clement LC, Avila-Casado C,Macé C et al (2011) Podocyte-secreted angiopoietin-like-4 mediates proteinuria in glucocorticoid-sensitive nephrotic syndrome. Nat Med 17:117-122
16. Reiser J, Chapman H (2014) Soluble urokinase-type plasminogen activator receptor in FSGS: stirred but not shaken. J Am Soc Nephrol(May)
17. Yu CC, Fornoni A, Weins A et al (2013) Abatacept in B7-1-positive proteinuric kidney disease. N Engl J Med 369:2416-2423
18. Stanescu HC, Arcos-Burgos M, Medlar A et al (2011) Risk HLADQA1 and PLA(2)R1 alleles in idiopathicmembranous nephropathy. N Engl J Med 364:616-626
19. De Abreu FB, Wells WA, Tsongalis GJ (2013) The emerging role of the molecular diagnostics laboratory in breast cancer personalized medicine. Am J Pathol 183:1075-1083
20. Hénique C, Papista C, Guyonnet L et al (2014) Update on crescentic glomerulonephritis. Semin Immunopathol. doi:10.1007/s00281-014-0435-7 (this issue)
21. Schmid H, Boucherot A, Yasuda Yet al (2006)Modular activation of nuclear factor-kappaB transcriptional programs in human diabetic nephropathy. Diabetes 55:2993-300
22. Kretzler M, Cohen CD (2010) Integrative biology of renal disease: toward a holistic understanding of the kidney's function and failure. Semin Nephrol 3:439-442
23. Couser WG (2012) Basic and translational concepts of immune-mediated glomerular diseases. J Am Soc Nephrol 23:381-399